Aili Chen
Overview
Explore the profile of Aili Chen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
260
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Qiu S, Chen A, Li Q, Guo L, Cai J, Xue X
Crit Rev Biomed Eng
. 2024 Nov;
53(1):23-35.
PMID: 39612268
Using a random number table method, 124 nasopharyngeal carcinoma patients who received radiotherapy in the hospital from January 2020 to December 2021 were randomly divided into a control group of...
2.
Zhang Y, Jiang S, He F, Tian Y, Hu H, Gao L, et al.
Genome Biol
. 2023 Aug;
24(1):199.
PMID: 37653425
Background: Cancer patients can achieve dramatic responses to chemotherapy yet retain resistant tumor cells, which ultimately results in relapse. Although xenograft model studies have identified several cellular and molecular features...
3.
Ding H, Shen X, Chen A, Gu R, Fang Y, Li D
Materials (Basel)
. 2023 Aug;
16(16).
PMID: 37629938
Despite having a high early mechanical strength and using sulfoaluminate cement as the primary cementitious material, self-compacting repair mortar (SCRM) suffers from rapid hydration rates leading to construction time constraints....
4.
Chen A, Hu S, Wang Q
Blood Sci
. 2022 Apr;
1(1):73-76.
PMID: 35402804
Individual tumors comprise genetically and epigenetically heterogeneous subclones, each of which is presumably associated with a distinct function, such as self-renewal or drug sensitivity. The dissection of such intratumoral heterogeneity...
5.
Hu Y, Chen A, Zheng X, Lu J, He H, Yang J, et al.
Natl Sci Rev
. 2021 Oct;
6(3):469-479.
PMID: 34691895
Standard chemotherapy regimens for remission induction of pediatric acute myeloid leukemia (AML) are associated with significant morbidity and mortality. We performed a cohort study to determine the impact of reducing...
6.
Hong Y, Zhang D, Zhou X, Chen A, Abliz A, Bai J, et al.
Genomics Proteomics Bioinformatics
. 2021 Oct;
20(1):177-191.
PMID: 34624550
Postzygotic mutations are acquired in normal tissues throughout an individual's lifetime and hold clues for identifying mutagenic factors. Here, we investigated postzygotic mutation spectra of healthy individuals using optimized ultra-deep...
7.
Hu Y, Chen A, Gao L, He H, Jiang S, Zheng X, et al.
Blood Adv
. 2021 Mar;
5(7):1837-1847.
PMID: 33787864
Treatment refusal and death as a result of toxicity account for most treatment failures among children with acute myeloid leukemia (AML) in resource-constrained settings. We recently reported the results of...
8.
Zhao J, Sui P, Wu B, Chen A, Lu Y, Hou F, et al.
Leukemia
. 2020 Jun;
35(2):595-600.
PMID: 32503976
No abstract available.
9.
Hayashi Y, Zhang Y, Yokota A, Yan X, Liu J, Choi K, et al.
Cancer Discov
. 2018 Aug;
8(11):1438-1457.
PMID: 30139811
Myelodysplastic syndromes (MDS) are heterogeneous hematopoietic disorders that are incurable with conventional therapy. Their incidence is increasing with global population aging. Although many genetic, epigenetic, splicing, and metabolic aberrations have...
10.
Zhan D, Zhang Y, Xiao P, Zheng X, Ruan M, Zhang J, et al.
Leuk Res
. 2017 Dec;
65:20-24.
PMID: 29253671
Genomic alterations underlying chemotherapy resistance remains poorly characterized in pediatric acute myeloid leukemia (AML). In this study, we used whole exome sequencing to identify gene mutations associated with chemo-resistance in...